DKSH and Kyowa Kirin Launch Strategic Partnership For Asia-Pacific Growth

DKSH Business Unit Healthcare, a prominent Strategic Healthcare Solutions Partner and a leading provider of Market Expansion Services for pharmaceutical, OTC, consumer health, and medical device companies, has forged a partnership with Kyowa Kirin Co., Ltd. (TSE:4151), a global specialty pharmaceutical company based in Japan, led by President and CEO Masashi Miyamoto.

This collaboration aligns with Kyowa Kirin's strategic initiative to enhance its business footprint in the Asia-Pacific region. The partnership includes a promotion and distribution agreement for the commercial rights to Kyowa Kirin's established medicines portfolio across South Korea, the Taiwan region, Singapore, Thailand, Malaysia, and Hong Kong & Macau SAR. Additionally, it covers global products such as Crysvita® in Singapore, Thailand, Malaysia, and Hong Kong & Macau SAR, as well as Poteligeo® in Singapore.

DKSH, renowned for its comprehensive suite of integrated solutions aimed at fostering sustainable growth for its client partners, has been selected by Kyowa Kirin as its strategic ally to establish a complete agency alliance business model. This partnership focuses on providing end-to-end healthcare solutions that enhance patient access to vital treatments. Leveraging DKSH's extensive knowledge in nephrology, well-established distribution networks, and strong commercial acumen, this collaboration marks a pivotal advancement in improving patient care and accessibility throughout the region.

"We are very confident about this new journey with DKSH. Given DKSH's proven healthcare expertise and commercial strength across Southeast Asia and North Asia, we are convinced we have chosen the right business partner to continue serving our patients, taking care of our employees and making people smile,” commented Abdul Mullick, Ph.D., Chief International Business Officer (CIBO), Kyowa Kirin.

Bijay Singh, Global Head Business Unit Healthcare, Member of the Executive Committee, DKSH, also said that, "We are thrilled to embark on this brand new partnership with Kyowa Kirin, especially as they chose DKSH as a regional partner across 6 markets. This collaboration reflects DKSH's commitment to driving growth for our clients while at the same time pursuing our mission of providing better healthcare to all patients in our markets. By combining our expertise and resources with Kyowa Kirin's excellent brands, we are confident we can provide a more cost-effective yet high quality commercial access solution that provides outstanding patient outcomes and customer service.”